Literature DB >> 23205061

Optimizing postoperative sexual function after radical prostatectomy.

Manuela Tutolo1, Alberto Briganti, Nazareno Suardi, Andrea Gallina, Firas Abdollah, Umberto Capitanio, Marco Bianchi, Niccolò Passoni, Alessandro Nini, Nicola Fossati, Patrizio Rigatti, Francesco Montorsi.   

Abstract

Erectile dysfunction (ED) is one of the complications associated with pelvic surgery. The significance of ED as a complication following pelvic surgery, especially radical prostatectomy (RP), lies in the negative impact that it has on patients' sexual and overall life. In the literature, rates of ED following RP range from 25% to 100%. Such variety is associated with pelvic dissection and conservation of neurovascular structures. Another important factor impacting on postoperative ED is the preoperative erectile function of the patient. Advances in the knowledge of pelvic anatomy and pathological mechanisms led to a refinement of pelvic surgical techniques, with attention to the main structures that if damaged compromise erectile function. These improvements resulted in lower postoperative ED rates and better erectile recovery, especially in patients undergoing RP. Furthermore, surgery alone is not sufficient to prevent this complication, and thus, several medical strategies have been tested with the aim of maximizing erectile function recovery. Indeed it seems that prevention of postoperative ED must be addressed by a multimodal approach. The aim of this review is to give a picture of recent knowledge, novel techniques and therapeutic approaches in order to reach the best combination of treatments to reduce the rate of ED after pelvic surgery.

Entities:  

Keywords:  erectile function; prostate cancer; radical prostatectomy

Year:  2012        PMID: 23205061      PMCID: PMC3491757          DOI: 10.1177/1756287212450063

Source DB:  PubMed          Journal:  Ther Adv Urol        ISSN: 1756-2872


  133 in total

1.  Reliability of classification of erectile function domain of the international index of erectile function in patients affected by localized prostate cancer who are candidates for radical prostatectomy.

Authors:  Alberto Briganti; Andrea Gallina; Andrea Salonia; Elena Farina; Giuseppe Zanni; Patrizio Rigatti; Francesco Montorsi
Journal:  Urology       Date:  2005-11       Impact factor: 2.649

Review 2.  Physiology of penile erection and pathophysiology of erectile dysfunction.

Authors:  Robert C Dean; Tom F Lue
Journal:  Urol Clin North Am       Date:  2005-11       Impact factor: 2.241

3.  Erythropoietin promotes the recovery of erectile function following cavernous nerve injury.

Authors:  Mohamad E Allaf; Ahmet Hoke; Arthur L Burnett
Journal:  J Urol       Date:  2005-11       Impact factor: 7.450

4.  Acetyl-L-carnitine plus propionyl-L-carnitine improve efficacy of sildenafil in treatment of erectile dysfunction after bilateral nerve-sparing radical retropubic prostatectomy.

Authors:  Giorgio Cavallini; Fabio Modenini; Giovanni Vitali; Aleardo Koverech
Journal:  Urology       Date:  2005-11       Impact factor: 2.649

Review 5.  Sexual dysfunction after radical prostatectomy: prevalence, treatments, restricted use of treatments and distress.

Authors:  Andrew G Matthew; Adam Goldman; John Trachtenberg; John Robinson; Sheri Horsburgh; Kristen Currie; Paul Ritvo
Journal:  J Urol       Date:  2005-12       Impact factor: 7.450

6.  Sildenafil inhibits beta-adrenergic-stimulated cardiac contractility in humans.

Authors:  Barry A Borlaug; Vojtech Melenovsky; Tricia Marhin; Patricia Fitzgerald; David A Kass
Journal:  Circulation       Date:  2005-10-25       Impact factor: 29.690

7.  Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function ("trifecta").

Authors:  Fernando J Bianco; Peter T Scardino; James A Eastham
Journal:  Urology       Date:  2005-11       Impact factor: 2.649

8.  hMaxi-K gene transfer in males with erectile dysfunction: results of the first human trial.

Authors:  Arnold Melman; Natan Bar-Chama; Andrew McCullough; Kelvin Davies; George Christ
Journal:  Hum Gene Ther       Date:  2006-12       Impact factor: 5.695

9.  Early use of vacuum constriction device following radical prostatectomy facilitates early sexual activity and potentially earlier return of erectile function.

Authors:  R Raina; A Agarwal; S Ausmundson; M Lakin; K C Nandipati; D K Montague; D Mansour; C D Zippe
Journal:  Int J Impot Res       Date:  2006 Jan-Feb       Impact factor: 2.896

10.  Early combination therapy: intracavernosal injections and sildenafil following radical prostatectomy increases sexual activity and the return of natural erections.

Authors:  K Nandipati; R Raina; A Agarwal; C D Zippe
Journal:  Int J Impot Res       Date:  2006-02-16       Impact factor: 2.896

View more
  6 in total

1.  Is active surveillance an appropriate approach to manage prostate cancer patients with Gleason Score 3+3 who met the criteria for active surveillance?

Authors:  Saleh Ghiasy; Amir Reza Abedi; Afshin Moradi; Seyed Yousef Hosseini; Morteza Fallah Karkan; Ghazal Sadri; Mohammadreza Davari
Journal:  Turk J Urol       Date:  2018-11-19

Review 2.  Systematic review and meta-analysis of the use of phosphodiesterase type 5 inhibitors for treatment of erectile dysfunction following bilateral nerve-sparing radical prostatectomy.

Authors:  Xiao Wang; Xinghuan Wang; Tao Liu; Qianwen He; Yipeng Wang; Xinhua Zhang
Journal:  PLoS One       Date:  2014-03-11       Impact factor: 3.240

3.  Efficacy of phosphodiesterase type 5 inhibitors in patients with erectile dysfunction after nerve-sparing radical prostatectomy: a systematic review and meta-analysis.

Authors:  Hyeok Jun Goh; Jeong Min Sung; Kwang Hyun Lee; Jung Ki Jo; Kyu Nam Kim
Journal:  Transl Androl Urol       Date:  2022-02

4.  Improvement in sexual function after robot-assisted radical prostatectomy: A rehabilitation program with involvement of a clinical sexologist.

Authors:  Christina Ljunggren; Peter Ströberg
Journal:  Cent European J Urol       Date:  2015-05-04

5.  Development of UK recommendations on treatment for post-surgical erectile dysfunction.

Authors:  M G Kirby; I D White; J Butcher; B Challacombe; J Coe; L Grover; P Hegarty; G Jackson; A Lowndes; H Payne; J Rees; V Sangar; A Thompson
Journal:  Int J Clin Pract       Date:  2013-11-04       Impact factor: 2.503

Review 6.  Comparisons of regular and on-demand regimen of PED5-Is in the treatment of ED after nerve-sparing radical prostatectomy for Prostate Cancer.

Authors:  Shi Qiu; Zhuang Tang; Linghui Deng; Liangren Liu; Ping Han; Lu Yang; Qiang Wei
Journal:  Sci Rep       Date:  2016-09-09       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.